62 studies found for:    "Localized scleroderma"
Show Display Options
Rank Status Study
1 Recruiting Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
Conditions: Scleroderma, Localized;   Morphea;   Frontal Linear Scleroderma en Coup de Sabre;   Scleroderma, Circumscribed;   Scleroderma, Linear
Intervention: Other: Morphea
2 Recruiting Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized Scleroderma
Condition: Localized Scleroderma
Interventions: Device: Fractional carbon dioxide laser;   Device: Ultraviolet A1 phototherapy (UVA1)
3 Recruiting Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea
Conditions: Scleroderma, Localized;   Morphea;   Scleroderma, Circumscribed
Interventions: Procedure: UVA-1 Phototherapy;   Procedure: Placebo
4 Not yet recruiting Genetic Variants in Linear Localized Scleroderma
Condition: Morphea
Intervention: Other: skin biopsy
5 Completed Imiquimod in Children With Plaque Morphea
Condition: Scleroderma, Localized
Intervention: Drug: Imiquimod 5% cream
6 Withdrawn Imiquimod 5% Cream in Plaque-Type Morphea: A Pilot, Prospective Open-Label Study
Condition: Morphea
Intervention: Drug: imiquimod 5% cream (Aldara)
7 Unknown  Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.
Condition: Symmetric Limited Morphea.
Interventions: Other: Medium Dose UVA-1;   Other: High Dose UVA-1
8 Recruiting The CARRA Registry
Conditions: Juvenile Idiopathic Arthritis;   Systemic Lupus Erythematosus;   Mixed Connective Tissue Disease;   Juvenile Ankylosing Spondylitis;   Juvenile Dermatomyositis;   Localized Scleroderma;   Systemic Sclerosis;   Vasculitis;   Sarcoid;   Fibromyalgia, Primary;   Auto-inflammatory Disease;   Idiopathic Uveitis Idiopathic
Intervention:
9 Active, not recruiting A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
Condition: Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis)
Intervention: Drug: Rituximab
10 Completed Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix
Conditions: Keloid;   Scleroderma, Localized;   Acne Keloidalis;   Scars;   Granuloma Annulare
Intervention: Procedure: UVB Irradiation
11 Completed Efficacy and Safety of Imatinib in Scleroderma
Conditions: Scleroderma, Localized;   Scleroderma, Systemic
Intervention: Drug: imatinib mesylate
12 Completed UVA1 Light for Treatment of Scleroderma and Similar Conditions
Conditions: Scleroderma;   Keloids;   Other Fibrosing Conditions
Intervention: Device: German manufactured UVA1 light emitting device
13 Terminated UVA1 Light for Scleroderma and Similar Conditions
Conditions: Keloid;   Scleroderma;   Scars;   Granuloma Annulare;   Acne Keloidalis Nuchae
Intervention: Device: German manufactured UVA1 emitting light system
14 Recruiting Scleroderma Treatment With Autologous Transplant (STAT) Study
Condition: Systemic Scleroderma
Interventions: Procedure: peripheral blood stem cell transplantation;   Drug: cyclophosphamide;   Biological: anti-thymocyte globulin;   Other: questionnaire administration;   Other: laboratory biomarker analysis;   Other: quality-of-life assessment;   Biological: filgrastim;   Procedure: autologous hematopoietic stem cell transplantation;   Drug: mycophenolate mofetil;   Drug: plerixafor
15 Recruiting Treatment of Refractory Sever Systemic Scleroderma by Injection of Allogeneic Mesenchymal Stem Cells
Conditions: SYSTEMIC SCLERODERMA;   ALLOGENEIC MESENCHYMAL STEM CELLS;   ADULT
Intervention: Biological: INJECTION OF ALLOGENEIC MESENCHYMAL STEM CELLS
16 Unknown  Influenza Vaccination in Patients With Scleroderma
Condition: Influenza Vaccine in Scleroderma
Intervention: Biological: Influenza vaccine
17 Unknown  Effect of Sildenafil on the Microcirculatory Blood Flow and Endothelial Progenitor Cells in Systemic Sclerosis
Conditions: Scleroderma, Systemic;   Scleroderma, Diffuse;   Scleroderma, Limited;   Raynaud Phenomenon
Interventions: Drug: Sildenafil citrate;   Drug: Placebo
18 Not yet recruiting Zibotentan Better Renal Scleroderma Outcome Study
Conditions: Scleroderma;   Scleroderma Renal Crisis;   Chronic Kidney Disease
Intervention: Drug: Zibotentan
19 Completed
Has Results
Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis
Condition: Scleroderma
Intervention: Drug: dasatinib
20 Completed A Study to Evaluate the Safety and Efficacy of Abatacept in Patients With Diffuse Systemic Sclerosis (Scleroderma)
Conditions: Scleroderma, Diffuse;   Scleroderma, Systemic
Intervention: Drug: Abatacept

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years